AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Effect of Kangaroo Care on Pain in Infants Receiving Phototherapy

RecruitingNAAges 2 Days - 7 DaysAllMarmara University
💬

In plain words

What the trial is, and whether it could suit you

This study aims to evaluate and compare the effects of two different kangaroo care (KC) models on pain management in neonates undergoing phototherapy. Specifically, the research investigates the impact of mother-administered versus nurse-administered kangaroo care on pain levels during mandatory heel-stick blood sampling. The study seeks to determine which provider model is more effective in reducing procedural pain for these vulnerable newborns, thereby optimizing comfort and care protocols during phototherapy treatment.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Voluntary participation of the mother * Gestational age of 38 weeks or more * Diagnosis of physiological hyperbilirubinemia only * Serum bilirubin level within the moderate-high range (13-18 mg/dL) according to the Turkish Neonatal Society Guideline for the Management, Follow-up, and Treatment of Neonatal Jaundice (2022 update) * Postnatal age between 2 and 7 days * Absence of any condition preventing the infant from feeding * Absence of any maternal health condition that would preclude the application of kangaroo care * Ability of the mother to speak Turkish and to understand the information provided about the study Exclusion Criteria: * Gestational age less than 34 weeks or 38 weeks and above * Diagnosis of sepsis or any other systemic infection * Presence of congenital anomalies * Diagnosis of pathological jaundice * Use of antibiotic therapy * Serum bilirubin level greater than 18 mg/dL * Postnatal age greater than 7 days * Mother's refusal to participate in the study
💊

What it tests

  • Kangaroo Care
  • Routine Care
📍

Where

1 site
Başakşehir Çam and Sakura City Hospital
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy